Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Solicitation opportunity from Department Of Defense was posted on May 7, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program

Closed
HT9402-26-Q-9301Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412
New
Federal
SNS Pharmaceutical Logistic Replenishment Requirement
Solicitation # 75A50326R00007
The Department of Health and Human Services, through the Administration for Strategic Preparedness and Response, is soliciting proposals under solicitation 75A50326R00007 for the replenishment of expired or expiring pharmaceuticals for the Strategic National Stockpile. This is a full and open competition resulting in a twelve-month Firm Fixed Price contract. The scope includes the procurement of various FDA-approved pharmaceuticals, such as Dopamine Hydrochloride, Norepinephrine, and Morphine Sulfate, with the government reserving the right to increase awarded quantities by up to 20 percent. Deliveries are FOB Destination and may be required at up to nine locations across the contiguous United States and Hawaii. Award decisions will be based on a best-value tradeoff, prioritizing technical capability and past performance significantly over price. Technical evaluation focuses on product compliance, regulatory requirements, and the ability to meet delivery schedules. Strict quality standards are mandated, including adherence to current Good Manufacturing Practice regulations, specific temperature controls between 20C and 25C during storage and transit, and a requirement that products retain at least 90 percent of their FDA-approved shelf life upon receipt. Proposals must be submitted in two volumes by September 18, 2026, including a technical volume, a pricing volume, and a proposal submission worksheet. Large businesses are additionally required to submit subcontracting plans via the SBCX system.
Aspr/orm-Sns

POSTED

1 day ago

DEADLINE

in 6 days

AI Contract Overview

Show more

The Department of War, through the Defense Health Agency, is soliciting quotes under solicitation HT9402-26-Q-9301 to establish Uniform Formulary Blanket Purchase Agreements and Uniform Formulary Additional Discount Program Agreements for pharmaceutical agents within two specific drug classes: ADHD Stimulants and BRAF-MEK Inhibitors. The procurement is mandated by 10 U.S.C. §1074g and implemented under 32 CFR §199.21, requiring the Pharmacy and Therapeutics Committee to evaluate both clinical effectiveness and cost effectiveness before recommending drugs for inclusion in the Uniform Formulary and determining their tiered classification as generic, formulary, Basic Core Formulary, Extended Core Formulary, or non-formulary. The submission deadline is June 29, 2026, with a pre-quotation teleconference scheduled for May 13, 2026, and responses must be submitted electronically to the designated point of contact. Offerors must be registered in the System for Award Management with a valid Unique Entity ID, and all pricing must be submitted in NDC-11 format aligned with the contractor’s Federal Supply Schedule contract, including the Industrial Funding Fee. Evaluation is based on a trade-off between cost, including Non-Federal Average Manufacturing Price, Federal Ceiling Price compliance, and Additional Discount Program refund offers, and clinical factors such as formulary tier placement, step therapy designation, and therapeutic equivalence as defined by the FDA's Orange Book. The resulting agreements will govern the supply of pharmaceuticals to Military Treatment Facilities, TRICARE Mail Order Pharmacy, and the TRICARE retail network, with performance centered at the Defense Health Agency's office in San Antonio, Texas. Acceptance of prices and award of the agreements are contingent upon final approval by the Director of the Defense Health Agency following the P&T Committee’s recommendation. Contractors must adhere to strict compliance requirements including automatic termination if the underlying FSS contract is terminated, notification of asset transfers within one business day, mandatory generic substitution for FDA-approved “A” rated equivalents, and exclusion of hospital unit dose and injectable NDCs. Invoicing is handled quarterly based on utilization data, with payment terms of 70 days after reconciliation, and refunds are processed according to TRICARE Retail Refund Program guidelines. Packaging, marking, and delivery terms are not explicitly defined beyond the requirement to comply with formulary and NDC specifications, and no formal contract clauses, inspection details beyond regulatory compliance, or

General Info

Department of War solicits pharmaceutical pricing for ADHD and oncological drugs under Military Health System benefits.

Agency

Department Of Defense → Defense Health AgencyView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

San Antonio, TX, 78230, USA

Set-Aside

NONE

Documents

(5)

UF BPA NDC Price List for ADHD Agents - Stimulants August 2026

XLSXprice-list

RFQ HT9402-26-Q-9301 Department of War Uniform Formulary

PDFrfq

UF BPA NDC Price List for Oncological Agents - BRAF-MEK Inhibitors Aug 2026

XLSXprice-list

August 2026 Pharmacy Operations Support Contract P&T Meeting Reporting

XLSXreport

NDC Price List FAQ for RFQ Submission

PDF2 pagesfaq

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Health Agency
Contacts2 people available
OfficeAURORA, CO, 80011, USA
Organization / Agency
Department Of Defense → Defense Health Agency
View Agency Profile
Office AddressAURORA, CO, 80011, USA
Contacts
Keith Marasigan

Full Description

Show more

The Department of War (DoW) is required by law (10 U.S.C. § 1074g) to establish an effective, efficient, integrated pharmacy benefits program for the Military Health System (MHS) which includes the purchase pharmaceutical agents. The law and implementing regulation (32 CFR Section 199.21) describe the process by which the DoW Pharmacy and Therapeutics (P&T) Committee will consider the relative clinical effectiveness and relative cost effectiveness of pharmaceutical agents in a therapeutic class in recommending the selection of agents for the DoW Uniform Formulary (UF) and, for cost sharing purposes, the classification of a pharmaceutical agent as generic, formulary, Basic Core Formulary (BCF), Extended Core Formulary (ECF), or non-formulary (NF). Prior to the scheduled P&T Committee meeting, a Request for Quotation (RFQ) for pharmaceutical agents within Drug Classes identified for placement on the UF has been issued to obtain quotes from industry. The Defense Health Agency may award Uniform Formulary Blanket Purchase Agreements (UF BPA) and the Uniform Formulary Additional Discount Program Agreements (UF ADP) based on the UF decision. This process is described in the attached RFQ.



P&T COMMITTEE MEETING: The following August 2026 drug classes/subclasses will be reviewed:


a. ADHD Agents – Stimulants


  • AZSTARYS
  • COTEMPLA XR-ODT
  • DYANAVEL XR
  • JORNAY PM
  • MYDAYIS
  • QUILLICHEW ER
  • QUILLIVANT XR
  • XELSTRYM

b. Oncological Agents - BRAF-MEK Inhibitors


  • BRAFTOVI
  • COTELLIC
  • MEKINIST
  • MEKTOVI
  • TAFINLAR
  • ZELBORAF

The RFQ, including UF BPA and UF ADP appendices are attached here in. The instructions, important deadlines, and points of contact are in document, RFQ HT9402-26-Q-9301. Pre-quotation teleconference is on May 13, 2026. Details are stated in Part 2.4. Pre-Quotation Teleconference.

More opportunities from Department Of Defense → Defense Health Agency

Same awarding agency

NAICS: 221310
New
Federal
Reverse Osmosis System
Solicitation # HT001426QE043
Solicitation HT001426QE043 is an unrestricted, firm-fixed-price request for offers issued by the Defense Health Agency to procure, deliver, and install a sterile processing critical water system for the Tignor Dental Clinic at Fort Eustis, Virginia. The requirement specifically identifies the Ameri-Water SRB-800-115-FT reverse osmosis system, including a 55-gallon storage tank, distribution pump, phosphate cartridge filter feed system, and UV disinfection system. While originally a brand-name only procurement, Amendment 0001 updated the requirement to brand name or equal and extended the proposal submission deadline to September 16, 2026, by 4:00 PM EST. The contract will be awarded using the Lowest Price Technically Acceptable (LPTA) process, where offers are first evaluated for technical capability and then selected based on the lowest price. The contractor is responsible for all labor, materials, and installation, including final tie-in connections, system commissioning, and the removal of all packaging debris. Delivery is required within 60 days of the order or notice to proceed, with training to be conducted concurrently with or immediately following installation. Compliance with MIL-STD-130 and MIL-STD-129 for item marking and labeling is mandatory, and all payment requests must be processed through the Wide Area WorkFlow system.
Water Supply and Irrigation Systems

POSTED

1 day ago

DEADLINE

in 4 days
View Details
NAICS: 339112
New
Federal
Automated Endoscope Reprocessor (BAMC, San Antonio, Texas)
Solicitation # HT940826QE040
Solicitation HT940826QE040 is a combined synopsis and request for quote issued by the Defense Health Agency for the procurement and installation of five automated endoscope reprocessors (AERs) at Brooke Army Medical Center in San Antonio, Texas. The scope of work includes the installation of units across the Gastroenterology, Pulmonary, and Pediatrics departments, as well as the deinstallation and hauling away of twelve existing Olympus OER Pro/Elite systems. The required AERs must be FDA Class II Medical Devices with 510(k) premarket notification, featuring dual-basin designs with cycle times of approximately 22 minutes and compliance with AS/NI/AAMI ST91 and CDC infection prevention guidelines. The contract also requires the provision of compatible hookup blocks, water filtration assemblies, vapor management accessories, a one-year commercial warranty, and comprehensive on-site clinical training for staff. This is a firm-fixed-price acquisition that is not set aside for small business concerns, though it allows for HUBZone price evaluation preferences. Award will be based on the most advantageous offer, considering price, technical literature demonstrating compliance with specifications, and the delivery and installation timeframe. All items must be delivered by November 15, 2026, and must adhere to DoD item unique identification and marking standards per MIL-STD-130 and MIL-STD-129. Quotes must be submitted electronically to the designated points of contact by September 16, 2026. Payment will be processed electronically through the Wide Area WorkFlow (WAWF) system.
Surgical and Medical Instrument Manufacturing

POSTED

1 day ago

DEADLINE

in 4 days
View Details
NAICS: 621991
New
Federal
Costal Cartilage Allograft (BAMC, San Antonio, Texas)
Solicitation # HT940826QE041
Solicitation HT940826QE041 is a request for quote issued by the Defense Health Agency to procure human donor costal cartilage allografts for surgical reconstruction at Brooke Army Medical Center in San Antonio, Texas. The requirement is for solid, malleable rib cartilage pieces available in various sizes and configurations, including two-piece options, supplied in a saline solution to maintain tissue integrity. The contract is structured as a firm-fixed-price arrangement with an as-needed delivery schedule, featuring a basic requirement and multiple option periods extending through September 30, 2030. Delivery requirements specify that routine orders be shipped promptly, while urgent requirements must be delivered within 48 hours. The acquisition is unrestricted and not set aside for small business concerns, although a 10 percent price evaluation preference is applied to HUBZone and other successful small business concerns. Award will be based on the most advantageous offer, evaluating both price and capability, including FDA and AATB compliance, licensure, and product literature. Contractors must adhere to strict marking and identification standards per MIL-STD-130 and MIL-STD-129, using two-dimensional data matrix symbology. Administrative requirements include the use of Wide Area WorkFlow for invoicing and reporting, and all electronic quotes must be submitted by the September 16, 2026, deadline to the designated points of contact.
Blood and Organ Banks

POSTED

1 day ago

DEADLINE

in 4 days
View Details
NAICS: 339112
New
Federal
Draeger Perseus A500
Solicitation # HT940626QE112
The Defense Health Agency is seeking to negotiate a firm-fixed-price sole source contract with Draeger Inc. for the procurement of seven Draeger Perseus A500 Anesthesia Workstations integrated with the Infinity Acute Care System. These units are intended for Winn Army Community Hospital at Fort Stewart, Georgia, as a one-for-one replacement for existing systems that have reached their ten-year service life. The acquisition includes the workstations, associated components, software licensing, and clinical support services to ensure operational uptime and patient safety. The contractor must be an Original Equipment Manufacturer authorized dealer, distributor, or reseller to maintain OEM warranty and service standards. The delivery is specified as FOB Destination to Fort Stewart, Georgia, with a delivery timeline of approximately eight to ten weeks following the award. The procurement falls under NAICS code 339112 for Surgical and Medical Instrument Manufacturing. While the agency intends to proceed with a sole source award to Draeger Inc. based on clinical standardization and MHS Genesis integration, it has issued a notice of intent allowing other vendors to submit capability statements by September 21, 2026, to challenge the sole source basis. All payment requests and receiving reports must be processed through the Wide Area WorkFlow system.
Surgical and Medical Instrument Manufacturing

POSTED

1 day ago

DEADLINE

in 9 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS